Dr. Morgenthau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 E 102nd St
New York, NY 10029Phone+1 212-241-5656
Education & Training
- Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2001 - 2004
- Tel Aviv University SacklerClass of 2001
Certifications & Licensure
- FL State Medical License 2020 - Present
- NY State Medical License 2007 - 2027
- MD State Medical License 2005 - 2007
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Right Atrial Mass as Manifestation of Sarcoidosis.Shyla Saini, Erin Eschbach, Barry Love, Krishna Patel, Adam Jacobi
JACC. Case Reports. 2025-02-19 - 1 citationsSpecific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis.Ana Devesa, Philip M Robson, Busra Cangut, Ravi Vazirani, Vittoria Vergani
Heart Rhythm. 2024-09-10 - Leveraging AI technology in sarcoidosis.Akiff Premjee, Lawrence Li, Srilakashmi Garikapati, Kwabena Nketiah Sarpong, Adam S Morgenthau
Current Opinion in Pulmonary Medicine. 2024-09-01
Grant Support
- Advanced multi-parametric 18F-FDG PET and MRI imaging parameters of response to immune suppressant therapy in patients with active cardiac sarcoidosisICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: